Cardiovascular Systems INC (CSII) Stock Value Rose While Champlain Investment Partners LLC Has Trimmed Holding by $5.57 Million

October 13, 2018 - By Clifton Ray

Investors sentiment increased to 1.27 in Q2 2018. Its up 0.41, from 0.86 in 2018Q1. It increased, as 10 investors sold CSII shares while 39 reduced holdings. 23 funds opened positions while 39 raised stakes. 27.95 million shares or 6.50% more from 26.24 million shares in 2018Q1 were reported. Deutsche Bankshares Ag holds 0.01% or 406,772 shares. Ameritas Inv Ptnrs Incorporated holds 0% or 2,803 shares. Cortina Asset Mngmt Limited Company holds 1.24% or 813,833 shares in its portfolio. 30 are owned by Sei Investments. Champlain Ltd Liability invested 0.76% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Legal And General Pcl holds 5,195 shares or 0% of its portfolio. Invesco Limited owns 0% invested in Cardiovascular Systems, Inc. (NASDAQ:CSII) for 224,952 shares. Credit Suisse Ag holds 43,908 shares or 0% of its portfolio. Teachers Retirement Systems Of The State Of Kentucky reported 34,232 shares. 31,856 were reported by Rhumbline Advisers. Automobile Association invested 0.32% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Swiss Bancorporation reported 57,800 shares or 0% of all its holdings. Metropolitan Life Ny owns 11,422 shares. Stratos Wealth Limited invested 0.01% of its portfolio in Cardiovascular Systems, Inc. (NASDAQ:CSII). Guernsey-based Bluecrest Management Ltd has invested 0.01% in Cardiovascular Systems, Inc. (NASDAQ:CSII).

Champlain Investment Partners Llc decreased its stake in Cardiovascular Systems Inc. (CSII) by 6.72% based on its latest 2018Q2 regulatory filing with the SEC. Champlain Investment Partners Llc sold 174,170 shares as the company’s stock rose 25.60% with the market. The institutional investor held 2.42 million shares of the health care company at the end of 2018Q2, valued at $78.14M, down from 2.59M at the end of the previous reported quarter. Champlain Investment Partners Llc who had been investing in Cardiovascular Systems Inc. for a number of months, seems to be less bullish one the $1.21B market cap company. The stock increased 0.61% or $0.21 during the last trading session, reaching $34.77. About 225,178 shares traded. Cardiovascular Systems, Inc. (NASDAQ:CSII) has risen 27.95% since October 13, 2017 and is uptrending. It has outperformed by 12.33% the S&P500.

Champlain Investment Partners Llc, which manages about $6.04B and $10.33B US Long portfolio, upped its stake in James River Group Holdings Ltd (NASDAQ:JRVR) by 432,765 shares to 547,065 shares, valued at $21.49 million in 2018Q2, according to the filing. It also increased its holding in Sensient Technologies Corporat (NYSE:SXT) by 233,465 shares in the quarter, for a total of 1.17M shares, and has risen its stake in Blackbaud Inc. (NASDAQ:BLKB).

Analysts await Cardiovascular Systems, Inc. (NASDAQ:CSII) to report earnings on October, 24. They expect $-0.05 earnings per share, up 16.67 % or $0.01 from last year’s $-0.06 per share. After $0.11 actual earnings per share reported by Cardiovascular Systems, Inc. for the previous quarter, Wall Street now forecasts -145.45 % negative EPS growth.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Ratings Coverage

Among 2 analysts covering Cardiovascular Systems (NASDAQ:CSII), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cardiovascular Systems had 2 analyst reports since June 27, 2018 according to SRatingsIntel. Bank of America upgraded the shares of CSII in report on Wednesday, June 27 to “Buy” rating.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>